scispace - formally typeset
E

Eugene Braunwald

Researcher at Brigham and Women's Hospital

Publications -  1758
Citations -  278949

Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18

Kausik K. Ray, +8 more
- 01 Apr 2007 - 
TL;DR: Among ACS patients, diabetes was associated with both greater inflammation and higher glucose levels and patients with both hyperglycaemia and inflammation had worse outcomes, and better control of both inflammation and hyper glycaemia should be assessed in future ACS trials as a means to reduce the cardiovascular risk among diabetics.
Journal ArticleDOI

Effects of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tensions.

Robert E. Rude, +7 more
- 01 Jun 1982 - 
TL;DR: It is concluded that circulating PFCs reduce acute regional myocardial ischemia during ventilation with either 100% O2 or ambient air, and that PFC-O2 treatment augments myocardian O2 availability in the central ischemic zone.
Journal ArticleDOI

The Incidence and Management of "Medical" Complications Following Cardiac Operations

John F. Williams, +2 more
- 01 Oct 1965 - 
Journal ArticleDOI

Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction

Jessica L. Mega, +6 more
- 05 Jun 2007 - 
TL;DR: Women had similar relative and greater absolute risk reductions than men when treated with enoxaparin compared with unfractionated heparin as adjunctive therapy with fibrinolysis in the ExTRACT-TIMI 25 study.
Journal ArticleDOI

A cost-effectiveness model for coronary thrombolysis/reperfusion therapy

Glenn Laffel, +2 more
- 01 Nov 1987 - 
TL;DR: Therapeutic strategies involving intravenous administration of thrombolytic agents were found to be consistently more cost effective than were strategies involving intracoronary administration of THS agents and primary angioplasty.